METabolic MODulation to Enhance Insulin Sensitivity and Mitochondrial Function in Type 1 Diabetes (MetMod-T1D)

Clinical trial NCT07699380 · RECRUITING

Trial details

NCT number: NCT07699380
Sponsor: University of Washington
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Type 1 Diabetes (T1D)Metabolic Diseases Glucose Metabolism Disorders Endocrine System Diseases Autoimmune Diseases Immune System Diseases Diabetes Melletus, Type 1 Nutritional and Metabolic Diseases Combination Therapy

Start date: 2026-06-01
Primary completion: 2029-12-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.